Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
579.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.347%)
Market Cap: £841.81m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Saga successfully refinances corporate debt

30 Jan 2025 07:00

RNS Number : 1947V
SAGA PLC
30 January 2025
 

This announcement contains inside information.

 

30 January 2025

Saga plc

Saga successfully refinances corporate debt in full

 

Saga plc (Saga or the Group), the UK's specialist in products and services for people over 50, announces that it has secured new credit facilities (the New Facilities) which will refinance the Group's corporate debt in full. The New Facilities materially enhance the Group's liquidity position, significantly increase covenant headroom and provide funding certainty as the Group moves to execute its growth plans.

The New Facilities, agreed by Saga subsidiary, Saga MidCo Limited, with certain funds and accounts on HPS Investment Partners' direct lending platform, comprise:

· a £335.0m term loan facility that will be drawn to:

repay the £250.0m Senior Unsecured Notes, maturing July 2026;

repay the £75.0m drawings under the £85.0m loan facility with Roger De Haan, maturing April 2026; and

partially fund transaction costs.

· a £100.0m delayed-draw term loan facility that is available for three years and may be drawn for certain purposes, including the repayment of amortisation within the Ocean Cruise ship debt facilities, M&A and capital investment; and

· a £50.0m revolving credit facility.

The term loan and delayed-draw term loan facilities, which offer significant early repayment flexibility, will mature in January 2031 and are subject to a margin ratchet based on Group net leverage (ranging from 625bps to 700bps), priced with an initial margin of 675bps over SONIA, which will reduce as the Group de-levers. The initial blended pro forma interest rate will be c.7.6% in combination with the low-cost, fixed rate Ocean Cruise ship debt facilities which will be retained on existing terms.

Closing of the New Facilities is subject to customary conditions and is expected to take place by 31 March 2025, together with the repurchase, repayment and cancellation of the £250.0m Senior Unsecured Notes, the £85.0m loan facility with Saga Chairman, Roger De Haan, and the £50.0m revolving credit facility. 

The move to refinance follows Saga's announcement on 16 December 2024 of a 20-year partnership for motor and home insurance with Ageas UK and the sale of its Insurance Underwriting business.

The Group was advised on the transaction by Lazard & Co and Freshfields LLP.

 

Mark Watkins, Saga Group Chief Financial Officer, said:

"This refinancing represents a significant milestone for Saga, providing funding certainty as we target long-term sustainable growth. HPS' substantial investment is a validation of the strength of Saga, our brand, our customer base, our people and the long-term business opportunities we see ahead."

END

 

For further information, please contact:

 

Saga plc

 

Emily Roalfe, Director of Investor Relations and Treasury

Tel: 07732 093 007

 

Email: emily.roalfe@saga.co.uk

 

 

Headland Consultancy

 

Susanna Voyle

Tel: 07980 894 557

Will Smith

Tel: 07872 350 428

 

Tel: 020 3805 4822

 

Email: saga@headlandconsultancy.com

 

Notes to editors

Saga is a specialist in the provision of products and services for people over 50. The Saga brand is one of the most recognised and trusted brands in the UK and is known for its high level of customer service and its high-quality, award-winning products and services including cruises and travel, insurance, personal finance and media. www.saga.co.uk

 

Lazard & Co., Limited (Lazard), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as financial adviser to Saga and no one else in connection with the New Facilities and will not be responsible to anyone other than Saga for providing the protections afforded to clients of Lazard nor for providing advice in relation to the New Facilities or any other matters referred to in this announcement. Neither Lazard nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard in connection with this announcement, any statement contained herein or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKVKRVKUAUAR
Date   Source Headline
26th May 20269:00 amRNSNotice of AGM/ Annual Report and Accounts
12th May 20264:23 pmRNSTotal Voting Rights
8th May 202611:45 amRNSIssue of Equity
23rd Apr 20264:42 pmRNSDirector/PDMR Shareholding
23rd Apr 20264:40 pmRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSPreliminary results for the year ended 31 Jan 2026
23rd Mar 20261:59 pmRNSCommittee Changes
3rd Mar 20267:00 amRNSAppointment of Joint Corporate Brokers
27th Feb 20264:00 pmRNSDirectorate change
29th Jan 20267:00 amRNSTrading Update
16th Dec 20257:00 amRNSSaga and Ageas Insurance partnership goes live
30th Sep 20252:40 pmRNSHolding(s) in Company
29th Sep 202510:15 amRNSDirector/PDMR Shareholding
24th Sep 20257:00 amRNS2025-26 interim results statement
15th Jul 20259:00 amRNSTotal Voting Rights
14th Jul 20257:00 amRNSSaga Money launches partnership with NatWest
9th Jul 202512:00 pmRNSCommittee changes
9th Jul 202511:49 amRNSIssue of Equity
1st Jul 20253:57 pmRNSHolding(s) in Company
1st Jul 20252:09 pmRNSAcromas Insurance Company Limited Completion
26th Jun 20251:49 pmRNSDirector/PDMR Shareholding
24th Jun 20251:13 pmRNSResult of AGM
24th Jun 20259:02 amRNSDirector Declaration
24th Jun 20257:00 amRNSAGM Trading Update
29th May 20252:38 pmRNSDirector/PDMR Shareholding
20th May 20259:00 amRNSNotice of AGM
11th Apr 202511:00 amRNSHolding(s) in Company
10th Apr 20257:30 amRNSDirector/PDMR Shareholding
9th Apr 20253:54 pmRNSDirector/PDMR Shareholding
9th Apr 20257:01 amRNSDirectorate Change
9th Apr 20257:00 amRNSFinal Results
13th Mar 20258:00 amRNSDirector Declaration
28th Feb 20257:00 amRNSRepayment of corporate debt and new draw down
12th Feb 20258:00 amRNSDirector Declaration
30th Jan 20257:01 amRNSTrading Update
30th Jan 20257:00 amRNSSaga successfully refinances corporate debt
16th Dec 20247:00 amRNSSaga and Ageas agree new Insurance partnership
10th Dec 20243:57 pmRNSDirector Declaration
24th Oct 20247:35 amRNSDirector Declaration
24th Oct 20247:35 amRNSCorrection - Director Declaration
11th Oct 20247:00 amRNSInterim results for the six months ended 31 July
11th Oct 20247:00 amRNSSaga and Ageas in exclusive negotiations
2nd Oct 20247:00 amRNSResponse to Media Coverage
1st Oct 20244:23 pmRNSDelay to publication of H1 2024 results
1st Oct 20248:59 amRNSDirector Declaration
9th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 20243:00 pmRNSCorrection - Result of AGM
25th Jun 20242:19 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Trading Update
12th Jun 20244:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.